E-Therapeutics PLC
F:3AQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E-Therapeutics PLC
F:3AQ
|
UK |
|
Jiangsu Luokai Mechanical & Electrical Co Ltd
SSE:603829
|
CN |
|
Maire Tecnimont SpA
MIL:MAIRE
|
IT |
|
Plata Latina Minerals Corp
XTSX:EDCU
|
CA |
|
P
|
Paychest Inc
OTC:PYCT
|
US |
|
G
|
Global Escience Corp
OTC:GSNC
|
US |
|
Verra Mobility Corp
F:0YK
|
US |
|
E
|
Evd Bhd
KLSE:EVD
|
MY |
|
Marumae Co Ltd
TSE:6264
|
JP |
|
N
|
Newpark Resources Inc
F:NWP
|
US |
|
Bank of Ayudhya PCL
SET:BAY
|
TH |
|
S
|
Surplus Global Inc
KOSDAQ:140070
|
KR |
|
U
|
Uriel Gas Holdings Corp
CNSX:UGH
|
CA |
|
E
|
Ecarx Holdings Inc.
NASDAQ:ECX
|
CN |
|
Japan Property Management Center Co Ltd
TSE:3276
|
JP |
|
L
|
LSE Financial Services Ltd
KAR:LSEFSL
|
PK |
Bankruptcy Probability
E-Therapeutics PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
E-Therapeutics PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
E-Therapeutics PLC
LSE:ETX
|
52.4m GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
468.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
237.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
181.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
86.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
57.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
E-Therapeutics PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, E-Therapeutics PLC has no debt.
You can find a full breakdown on its Balance Sheet.
